Top compounds associated with response to CT62


Feature Type Standardized
Nominal ANOVA
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.033 0.3
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.037 0.3
mRNA myriocin CTRPv2 pan-cancer AAC -0.08 0.3
mRNA PF-750 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA FK866 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.3
mRNA GSK-650394 GDSC1000 pan-cancer AAC -0.034 0.3
mRNA foretinib CTRPv2 pan-cancer AAC -0.035 0.3
mRNA IPR-456 CTRPv2 pan-cancer AAC -0.037 0.3
Download CSV